We are live on ! Find out more
IBER

Ibere Pharmaceuticals
IBER

Delisted

IBER was delisted on the 1st of March, 2023.

Back to rankings

47 hedge funds and large institutions have $99.8M invested in Ibere Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 8 increasing their positions, 2 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

367% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 3

300% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 2

40% more capital invested

Capital invested by funds: $71.4M → $99.8M (+$28.3M)

24% more funds holding

Funds holding: 38 → 47 (+9)

Holders
47
Holders Change
+9
Holders Change %
+23.68%
% of All Funds
0.72%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
8
Reduced
2
Closed
3
Calls
$114K
Puts
–
Net Calls
+$114K
Net Calls Change
+$25K

Top Buyers

Rank Fund Capital Flow
1
Brown Advisory
Brown Advisory
Maryland
+$26.5M
2
SCM
Shaolin Capital Management
Florida
+$3.27M
3
PC
Periscope Capital
Ontario, Canada
+$2.43M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$2.36M
5
GCL
Glazer Capital LLC
New York
+$1.72M

Top Sellers

Rank Fund Capital Flow
1
AA
AQR Arbitrage
Connecticut
-$745K
2
AM
Ampfield Management
New York
-$432K
3
PCM
Prelude Capital Management
New York
-$35.3K
4
WAM
Wolverine Asset Management
Illinois
-$29K
5
Citadel Advisors
Citadel Advisors
Florida
-$49
Name Holding Trade Value Shares
Change 		Change in
Stake
HIH
26
HRS Investment Holdings
New York
$1.09M +$1.09M +112,050 New
Walleye Capital
27
Walleye Capital
New York
$1.06M +$1.06M +109,121 New
DFCM
28
Dark Forest Capital Management
Puerto Rico
$940K +$506K +52,027 +116%
FTCM
29
Fir Tree Capital Management
New York
$799K – – –
WA
30
Whitebox Advisors
Minnesota
$790K +$60.7K +6,246 +8%
Walleye Trading
31
Walleye Trading
New York
$778K +$778K +80,000 New
WRBC
32
W.R. Berkley Corp
Connecticut
$666K – – –
Goldman Sachs
33
Goldman Sachs
New York
$542K – – –
LCM
34
Lynwood Capital Management
Ontario, Canada
$515K +$500K +51,401 New
PI
35
PEAK6 Investments
Illinois
$486K – – –
ICMH
36
Integrity Capital Management (HK)
Hong Kong
$454K +$454K +46,717 New
TCM
37
Tegean Capital Management
New York
$444K +$444K +45,711 New
DMKJ
38
David M. Knott Jr
$348K +$350K +36,000 New
CSS
39
Cubist Systematic Strategies
Connecticut
$303K +$303K +31,209 New
Capstone Investment Advisors
40
Capstone Investment Advisors
New York
$243K – – –
RCM
41
Robinson Capital Management
Michigan
$174K +$13.1K +1,348 +8%
TIM
42
Timelo Investment Management
Ontario, Canada
$145K +$145K +14,900 New
PCM
43
Prelude Capital Management
New York
$97K -$35.3K -3,634 -27%
EH
44
EMG Holdings
Connecticut
$97K +$97.2K +10,000 New
PCM
45
Pinz Capital Management
New York
$84K +$84.3K +8,670 New
CI Investments Inc
46
CI Investments Inc
Ontario, Canada
$49K – – –
AA
47
Ancora Advisors
Ohio
$8K – – –
AA
48
AQR Arbitrage
Connecticut
– -$745K -76,900 Closed
AM
49
Ampfield Management
New York
– -$432K -44,542 Closed
WAM
50
Wolverine Asset Management
Illinois
– -$29K -3,051 Closed
1
2

IBER Hedge Fund Activity: Q4 2021 in Review

47 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Ibere Pharmaceuticals (IBER) for Q4 2021, worth a combined $99.8M — up 40% from $71.4M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new IBER positions and 3 closed out — a net gain of 11 holders — while 8 added to existing stakes and 2 trimmed.

The largest buyer was Brown Advisory, opening a new position worth an estimated $26.5M. The largest seller was AQR Arbitrage, exiting entirely with an estimated $745K sold.

  • 47 institutional investors held Ibere Pharmaceuticals (IBER) as of Q4 2021, up from 38 in Q3 2021.
  • Funds reported $99.8M of Ibere Pharmaceuticals stock for Q4 2021, up 40% quarter-over-quarter.
  • 14 funds opened new Ibere Pharmaceuticals positions in Q4 2021 and 3 closed out, a net change of +11 holders.
  • The largest Ibere Pharmaceuticals buyer in Q4 2021 was Brown Advisory, an estimated $26.5M added.
  • The largest Ibere Pharmaceuticals seller in Q4 2021 was AQR Arbitrage, an estimated $745K sold.

Based on aggregated 13F filings for Q4 2021.